Workplace Uniform Maker UniFirst Tops Q2 Profit Forecasts; Sales Come in Short
UniFirst on Wednesday reported better fiscal 2025 second-quarter profit than analysts had expected, but sales fell just shy.
The Manila Times3d
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
Operating expenses for the full year ended December 31, 2024 decreased by $5.4 million or 21% to $20.2 million, compared to the full year 2023, reflecting Vivos' continued cost-cutting initiatives ...